Stress Medicine

Somatic Symptom Disorder

Somatic Symptom Disorder · F45.1

Somatic symptom disorder: diagnostic criteria, relationship with autonomic nervous system dysregulation, differentiation from other conditions, and multidisciplinary treatment approaches.

2026-03-28

At a Glance

Somatic symptom disorder: diagnostic criteria, relationship with autonomic nervous system dysregulation, differentiation from other conditions, and multidisciplinary treatment approaches.

Definition and Overview

Somatic symptom disorder (SSD) is a diagnostic category reorganized in DSM-5 (2013) by consolidating the previously separate diagnoses of somatization disorder, undifferentiated somatoform disorder, pain disorder, and some cases of hypochondriasis [1]. Unlike DSM-IV, which required symptoms to be "medically unexplained," DSM-5 SSD can be diagnosed even when a medical cause exists, provided the psychological response to symptoms is excessive [1].

SSD occurs in approximately 5–7% of the general population, and in primary care settings, about 5–10% of patients meet criteria for SSD [2]. It is approximately twice as common in women as in men and most frequently presents after middle age [2]. Healthcare utilization rates are high, medical expenditures are increased, and functional impairment and reduced quality of life are prominent.

Diagnostic Criteria

The DSM-5 diagnostic criteria are as follows [1].

  • A. One or more somatic symptoms that are distressing or result in significant disruption of daily life. B. Excessive thoughts, feelings, or behaviors related to the somatic symptoms or associated health concerns, as manifested by at least one of the following: (1) disproportionate and persistent thoughts about the seriousness of symptoms; (2) persistently high level of anxiety about health or symptoms; (3) excessive time and energy devoted to these symptoms or health concerns. C. Although any one somatic symptom may not be continuously present, the state of being symptomatic is persistent (typically more than 6 months).

Relationship with the Autonomic Nervous System

Stress and psychological conflict can be converted into somatic symptoms through the autonomic nervous system. HPA axis activation triggers cortisol release, and sympathetic hyperactivity induces various somatic responses.

Central sensitization is one of the key neurobiological mechanisms of somatic symptom disorder [3]. Chronic stress and psychological arousal alter pain regulatory systems in the spinal cord and brain, causing normal bodily sensations to be interpreted as pain or discomfort. This is a mechanism shared with fibromyalgia, chronic fatigue syndrome, and irritable bowel syndrome.

Heart rate variability (HRV) studies consistently report that SSD patients have lower HRV than healthy controls, with particularly reduced parasympathetic indices [3]. This is associated with impaired emotional regulation capacity and may serve as a biomarker for predicting treatment response.

Association with Functional Somatic Syndromes

Somatic symptom disorder overlaps with numerous functional somatic syndromes [3]. Fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, persistent postural-perceptual dizziness (PPPD), non-cardiac chest pain, chronic low back pain, and some cases of tension-type headache are included in or co-occur with the SSD spectrum [3]. These conditions share autonomic nervous system dysfunction and central sensitization as common mechanisms [3].

Functional neurological symptom disorder (formerly conversion disorder) involves neurological symptoms such as paralysis, tremor, seizures, and visual or speech disturbances arising from functional mechanisms. Although classified separately from SSD, it is related.

Treatment

A Cochrane review has confirmed that cognitive behavioral therapy (CBT) is effective in reducing SSD symptoms [4]. Graduated increases in physical activity, improved sleep hygiene, and stress management techniques also contribute to symptom improvement.

Mindfulness-based cognitive therapy (MBCT) and acceptance and commitment therapy (ACT) are also used in SSD treatment [3]. Psychoeducation -- explaining the mechanisms of somatic symptoms in a way patients can understand -- is important for enhancing treatment motivation.

For pharmacotherapy, tricyclic antidepressants (TCAs, especially amitriptyline) and SSRIs/SNRIs are effective for improving pain, fatigue, and mood [3]. Treatment of comorbid depression and anxiety also contributes to SSD symptom improvement.

The quality of the physician-patient relationship has a strong influence on treatment outcomes. An approach that acknowledges and empathizes with symptoms while collaboratively setting goals for functional recovery is essential [3].

Frequently Asked Questions

Somatic symptom disorder is a condition in which various bodily symptoms (pain, fatigue, gastrointestinal discomfort, dizziness, etc.) are genuinely present, accompanied by excessive and persistent worry about those symptoms. Diagnostic tests often fail to identify a clear cause. Importantly, the symptoms are not fabricated but genuinely experienced, and the preoccupation and anxiety about these symptoms significantly interfere with daily functioning.

They are entirely different. The symptoms experienced by patients with somatic symptom disorder are real and not intentionally produced. Changes in the signal processing between the brain and body cause pain and discomfort to be amplified or perpetuated. This is fundamentally different from malingering or factitious disorder, which involve intentional production or exaggeration of symptoms. Patients with somatic symptom disorder are genuinely suffering and need professional help.

Stress, anxiety, and psychological conflict can be expressed as somatic symptoms through the autonomic nervous system. Sympathetic hyperactivity causes increased heart rate, gastrointestinal dysfunction (irritable bowel syndrome), muscle tension, and headaches. Reduced parasympathetic function impairs digestion, sleep, and immune function. Central nervous system pain regulatory mechanisms also change, leading to central sensitization, where normal stimuli are amplified into pain. These mechanisms constitute the actual physiological basis of somatic symptoms.

Cognitive behavioral therapy (CBT) is the treatment with the strongest evidence base. It aims to identify and modify excessive worry about symptoms and maladaptive behavioral patterns. Mindfulness-based therapies also help with symptom acceptance and emotional regulation. Antidepressants (SSRIs) may be effective for reducing pain and improving mood. The key is a therapeutic approach that focuses on functional recovery and quality of life improvement rather than pursuing further diagnostic testing to find the cause.

Even when multiple tests show no abnormalities, if symptoms are genuinely present, somatic symptom disorder or a functional somatic syndrome should be considered. In such cases, focusing on understanding the mechanisms and pursuing treatment is more helpful than additional diagnostic testing. Autonomic function testing and brain function assessments such as QEEG can identify the neurophysiological basis of somatic symptoms. Rather than dismissing symptoms or attributing them solely to psychological issues, an integrated approach is needed.

Related conditions include fibromyalgia, chronic fatigue syndrome (CFS), irritable bowel syndrome (IBS), persistent postural-perceptual dizziness (PPPD), non-cardiac chest pain, and functional neurological symptom disorder (conversion disorder). These conditions frequently overlap, and autonomic nervous system dysfunction and central sensitization are known to serve as common underlying mechanisms. An integrated evaluation and treatment approach is essential.

References

  1. [1] American Psychiatric Association (2013). "Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)." American Psychiatric Publishing. DOI
  2. [2] Creed F, Barsky A (2004). "A systematic review of the epidemiology of somatisation disorder and hypochondriasis." Journal of Psychosomatic Research, 56: 391-408. DOI PubMed
  3. [3] Henningsen P, Zipfel S, Sattel H, Creed F (2018). "Management of functional somatic syndromes and bodily distress." Psychotherapy and Psychosomatics, 87: 12-31. DOI PubMed
  4. [4] van Dessel N, den Boeft M, van der Wouden JC, Kleinstäuber M, Leone SS, Terluin B, et al. (2014). "Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults." Cochrane Database of Systematic Reviews, 11: CD011142. DOI PubMed
  5. [5] Lahmann C, Henningsen P, Brandt T, Strupp M, Jahn K, Dieterich M, et al. (2015). "Functional dizziness." General Hospital Psychiatry, 37: 109-115. DOI PubMed
Somatic Symptom DisorderFunctional Somatic SymptomsSomatization DisorderAutonomic SomatizationMedically Unexplained SymptomsPsychogenic

This content is provided for informational purposes only and is not a substitute for professional medical advice. If you have symptoms, please consult a qualified physician.

Are you experiencing related symptoms?

Get an accurate diagnosis at OSANG Neurosurgery.